Trial Details
COMPLETEDBasic Information
| Clinical ID | c3659 |
|---|---|
| Identifier | NCT01714726 |
| Trial Title | Evaluation of Efficacy and Safety of MEDI2070 in Patients With Active, Moderate-to-severe Crohn's Disease. |
| Trial URL | Visit Original Page |
Study Information
| Study Results | YES |
|---|---|
| Conditions | Crohn's Disease |
| Interventions | DRUG: MEDI2070|DRUG: placebo |
Participant Information
| Sponsor | AstraZeneca |
|---|---|
| City | Encinitas |
| Country/Region | United States |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE2 |
Time Information
| Start Date | 2013-02-01 |
|---|---|
| Primary Completion Date | 2014-05-20 |
| Completion Date | 2016-12-14 |